Gapping down
In reaction to disappointing earnings/guidance:
- COST -4.4%, SBUX -3.8% (Starbucks outlines growth agenda, co reiterated its FY19 targets at today's Investor Day), ADBE -2%, CNC -1.4% (Centene reaffirms 2018 guidance, provides in-line 2019 EPS guidance and announces 2-for-1 stock split), CIVI -1%
Other news:
- AXON -10.6% (Axovant Sciences licenses exclusive worldwide rights for GMA gangliosidosis and GM2 gangliosidosis from the University of Massachusetts Medical School; commences underwritten public offering of common shares)
- IDRA -8.9% (presents data from ongoing phase 2 expansion of the ILLUMINATE-204 trial investigating tilsotolimod in combination with ipilimumab)
- SHOP -5.9% (Shopify lower after filing preliminary prospectus supplement to its short form base shelf prospectus dated August 3, 2018)
- LNT -1.9% (prices offering of 7,268,673 shares of common stock at $44.85 per share)
Analyst comments:
- N/A.
